ArticleAmerican journal of cardiovascular disease2026
Protective effect of overweight status in aortic valve surgery: revisiting the obesity paradox.
Article in American journal of cardiovascular disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the relationship between body mass index (BMI) and postoperative mortality in patients undergoing aortic valve surgery, with an emphasis on exploring the presence and limits of the "obesity paradox", the phenomenon wherein overweight and mildly obese patients may experience lower mortality despite obesity's general association with adverse health outcomes.
methodsThe Nationwide Inpatient Sample (NIS) database was used to obtain data from adult patients who underwent aortic valve surgery between 2016 and 2020. BMI categories, as well as comorbidities, were identified using ICD-10 codes. Mortality rates across BMI categories were compared, and multivariate analysis was performed to adjust for comorbid conditions. This is a retrospective observational study.
resultsWe found 301,250 adult patients who underwent aortic valve surgery. Normal weight patients (n=226,490) had a mortality rate of 3.79%. Overweight (n=2,555) and obese (n=46,320) patients demonstrated significantly lower mortality rates of 1.17% (OR=0.30, 95% CI: 0.14-0.66; P=0.003) and 2.43% (OR=0.63, 95% CI: 0.55-0.73; P<0.001), respectively. Cachectic patients (n=835) had the highest mortality rate at 14.97% (OR=4.47, 95% CI: 2.87-6.96; P<0.001). Morbidly obese patients (n=25,450) had a mortality rate of 4.13%, which was not significantly different from normal-weight patients (OR=1.09, 95% CI: 0.94-1.26; P=0.23). These trends and statistical significance remained after multivariate logistic regression, accounting for demographics and comorbidities.
conclusionsThe partial obesity paradox is true in patients undergoing aortic valve surgery, with the lowest mortality occurring in overweight patients, followed by obese patients, and with cachexia having the highest mortality out of all groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.